Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Glenmark Pharmaceuticals ltd Audit Report / Information 2020

Dec 11, 2019

62608_rns_2019-12-11_53f5fdfa-72bd-4104-bfc2-ede476086c31.pdf

Audit Report / Information

Open in viewer

Opens in your device viewer

==> picture [65 x 34] intentionally omitted <==

Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow: Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow: Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow: Informationon significant relatedpartytransations on a consolidated basisasrequired by Ind AS-24 - 'Related Party Disclosures' are givenbelow:
Related parties withwhomtheGrouphastransacted during the period
KeyManagementPersonnel
Mr. Glenn Saldanha (Chairman&Managing Director)
Mrs. Cherylann Pinto (Executive Director)
Mr. VS Mani (Executive Director&Global Chief Financial Officer)
Mr.RajeshDesai(Non-executive Director)
Mr. Harish Kuber (Company Secretary & ComplianceOfficer)
Mrs.B.E.Saldanha (Non-executive Director)
Mr. D.R.Mehta (Non-executive Director)
Mr. Bernard Munos (Non-executive Director)
Mr.J.F.Ribeiro (Non-executive Director)
Dr.Brian W. Tempest (Non-executive Director)
Mr. Sridhar Gorthi (Non-executive Director)
Mr. Milind Sarwate (Non-executive Director)
Ms.SonaSairaRamasastry (Non-executive Directorwitheffect from 1 April 2019)
Enterprises over which significant influence exercised by key management personnel/directors
Glenmark Foundation
Glenmark Aquatic Foundation
Trilegal
Rs·in million
NatureofTransaction Asat
30September2019
Expenditure incurred forCSRactivities to
Glenmark Foundation 65.23
Glenmark Aquatic Foundation 47.15
Transactions with keymanagementpersonnel
Remuneration
- Mrs. Cherylann Pirito 19.11
-MrVS Mani 30.58
-Mr. Harish Kuber 2.29
Sitting fees paidtoNon-executive Directors 4.2
Asat
Related party balances 30September2019
Rsinmillion
(Payable)/ Advance given
Glenmark Foundation (1.00)

==> picture [74 x 75] intentionally omitted <==